Finance

Lists
Portfolios
Track your investments in one place, get AI insights, and more
Top movers in your lists
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXV
Health care
SIXV
Health care
SIXV
+3.52%
1,773.79
+60.29
+3.52%
1,713.501,738.091,782.961,738.09
SIXY
Discretionary
SIXY
Discretionary
SIXY
+1.88%
2,395.46
+44.14
+1.88%
2,351.322,360.162,405.742,360.16
SIXB
Materials
SIXB
Materials
SIXB
+1.44%
1,114.38
+15.83
+1.44%
1,098.551,102.591,127.531,102.59
SIXR
Staples
SIXR
Staples
SIXR
+1.08%
872.67
+9.34
+1.08%
863.33865.66879.45865.35
SIXT
Technology
SIXT
Technology
SIXT
-1.07%
3,696.86
-40.10
-1.07%
3,736.963,754.073,762.283,673.89
US market summary
Wall Street benchmarks broke a three-day losing streak to finish modestly higher. The S&P 500 rose 0.21% to close at 7,707.98, while the Dow Jones Industrial Average added nearly 120 points and the Nasdaq Composite ticked up 0.16%. Market sentiment was bolstered after an intervention in the bond market provided relief from recent multi-year highs in yields.
Dive deeper with AI
Treasury intervention triggers dramatic drop in bond yields
The U.S. Department of the Treasury announced a major liquidity support measure, revealing it will at least double the size of its government debt buyback operations for longer-dated notes starting September 9. Following the announcement, the 30-year Treasury bond yield recorded a significant daily decline, paring back after hitting a 19-year high above 5.33% earlier in the week.
Dive deeper with AI
Federal Reserve minutes reveal ongoing divide over inflation
Minutes from the Federal Open Market Committee's July meeting highlighted deep disagreements among central bankers regarding future monetary policy. Although interest rates were held steady during the session, three dissenting voters pushed for a quarter-point hike, with many participants indicating further tightening may be necessary if inflation does not consistently cool toward the 2% target.
Dive deeper with AI
Moderna paces healthcare surge on cancer vaccine momentum
Shares of Moderna skyrocketed over 175% to easily lead the S&P 500 following a significant development regarding its cancer vaccine. The massive surge propelled the stock to its highest valuation since 2023 and heavily supported the broader healthcare sector, which marked a 3.5% single-day gain to outpace lagging sectors like technology and industrials.
Dive deeper with AI
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
Google apps